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Objective: Literature examining the effects of total hip arthroplasty (THA) on subsequent body weight
gain is inconclusive. Determining the extent to which clinically relevant weight gain occurs following
THA has important public health implications.
Design:We used multi-variable logistic regression to compare data from one of the largest US-based THA
registries to a population-based control sample from the same geographic region. We also identiﬁed
factors that increased risk of clinically important weight gain speciﬁcally among persons undergoing
THA. The outcome measure of interest was weight gain of 5% of body weight up to 5 years following
surgery.
Results: The multi-variable adjusted [age, sex, body mass index (BMI), education, comorbidity and pre-
surgical weight change] odds ratio for important weight gain was 1.7 [95% conﬁdence interval (CI),
1.06, 2.6] for a person with THA as compared to the control sample. Additional arthroplasty procedures
during the 5-year follow-up further increased odds for important weight gain (OR ¼ 2.0, 95% CI, 1.4, 2.7)
relative to the control sample. A patient with THA had increased risk of important post-surgical weight
gain of 12% (OR ¼ 1.12, 95% CI, 1.08, 1.16) for every kilogram of pre-operative weight loss.
Conclusions: While ﬁndings should be interpreted with caution because of missing follow-up weight
data, patients with THA appear to be at increased risk of clinically important weight gain following
surgery as compared to peers. Patients less than 60 years and who have lost a substantial amount of
weight prior to surgery appear to be at particularly high risk of important post-surgical weight gain.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Total hip arthroplasty (THA) is a common major surgery con-
ducted in many countries. For example, in 2010, an estimated
300,000 hip arthroplasty procedures were conducted in the US1
and approximately 70,000 were conducted in England and
Wales2. Prevalence of obesity in persons who are potential candi-
dates for hip arthroplasty is especially high3,4, and is associated
with increased risks of short and long term complications and
higher costs5e7. Weight gain following THA has substantial public
health implications particularly for obese persons in their 50s ands to: D.L. Riddle, Virginia
Therapy, P.O. Box 980224,
4; Fax: 1-804-828-8111.
e), jasvinder.md@gmail.com
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en).
s Research Society International. P60s8 who are more likely than older persons to gain weight and to
develop or exacerbate obesity related disorders9e11.
Evidence examining the potential impact of THA on subsequent
weight gain is inconclusive. In the largest study we found, Paans
and colleagues determined whether the body weight of
618 patients changed from baseline to 1-year following THA12. In
addition, a sample of 100 patients were assessed 4.5 years
following surgery. During the ﬁrst year following surgery, over-
weight and obese patients [body mass index (BMI) 25 kg/m2] lost
3.2 kgs, on average, while patients with BMI <25 kg/m2 gained
approximately 1 kg. Weight loss among overweight and obese
patients was slightly greater 4.5 years after surgery. One limitation
of the study by Paans and colleagues was that height and weight
data were self-reported which likely led to an underestimation of
body weight13. Four other studies examined weight changes 1-year
following THA and ﬁndings were mixed with one study ﬁnding
a signiﬁcant gain in weight14 and three ﬁnding no statistically
signiﬁcant weight changes15e17. Three other studies with a longerublished by Elsevier Ltd. All rights reserved.
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particularly in obese patients (BMI  30) 218,19 or 3 years20
following surgery. With the exception of the work by Dowsey and
colleagues16, no other studies identiﬁed independent risk factors
for subsequent clinically important weight gain among THA
patients. Clinicians could potentially intervene with weight loss
interventions if they knew which patients were at risk for clinically
important weight gain subsequent to THA surgery.
The inconsistent evidence on the inﬂuence of THA on post-
surgical body weight is likely due to a variety of factors. Follow-up
times varied from 3 months to 4.5 years and sample sizes varied
from 64 to 618 patients recruited from multiple countries sug-
gesting the potential for social and cultural inﬂuences. No studies
recruited a population-based sample of similarly aged persons
without THA to account for weight gain attributable to normal
aging21e23. Most of the literature also has reported group-level
results rather than speciﬁcally focusing on the identiﬁcation of
subgroups of patients at risk for clinically important weight gains. If
a sub-group of THA patients are at risk for clinically important
weight gains, clinicians could direct treatment to this sub-group to
reduce risk of weight gain and subsequent complications, including
prosthetic loosening and failure24,25, cardiovascular and other
systemic disorders7,9,11. One purpose of our study was to determine
if persons undergoing THA are at risk for clinically important
weight gain (deﬁned as a 5% or greater increase inweight relative to
baseline)21,26e29 over a 5-year period as compared to an age and
gender matched population-based sample. Our second purpose
was to study a large sample comprised exclusively of persons with
THA to identify variables that increased risk of clinically important
weight gain.
Methods
The two study samples
Data for patients with THA were derived from the Mayo Clinic
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Fig. 1. The ﬁgure illustrates the ﬂow of hip arthroplasty patients through the stDecember 31, 2005 were considered for study inclusion. Revision
THAs were not considered for this study. We chose this time frame
to: (1) collect data on a large sample of patients receiving THA and,
(2) allow for use of the same deﬁnitions of potential confounders
and methods of height and weight data collection during clinic
visits and, (3) allow for a 5 year follow-up data for all THA persons
in the study. We further classiﬁed THA patients into those who did
and those who did not undergo additional arthroplasty surgeries of
either knee or of the contralateral hip during the 5-year post-
operative period.
We excluded persons who had bariatric surgery (n ¼ 15), and all
forms of cancer other than basal cell carcinoma because of risk of
cancer related weight loss (n ¼ 260) 2 years prior to or up to
5 years following the index THA. In addition, 35 persons under-
going THA did not provide informed consent. Therewere 693 THAs,
in 597 patients meeting criteria for inclusion in the study over the
time period. A total of 47 of these patients had no post-operative
weight data in the Mayo clinic system (see Fig. 1).
The second data source was the Rochester Epidemiology
Project (REP) a population-based medical records linkage system
based in Olmsted County, Minnesota, home of Mayo Clinic. The
REP has been continuously funded by NIH since 196630. Previous
work has indicated that the REP is a valid representation of
Olmsted County residents as compared to US Census Bureau
estimates30. The REP has been used extensively to study the
epidemiology of a variety of health problems including rheumatic
diseases31 and obesity32.
To estimate weight changes over time in the general population,
we used the REP to select from all persons residing in Olmsted
County and frequency matched for age, sex and time, within
30 days, to the dates of the index THA surgeries based on clinic visit
dates. Frequency matching randomly selects persons from the
population based on selected variables and can bemore statistically
efﬁcient than more traditional matching approaches33. Based on an
a priori power analysis, we selected a random sample of 277
persons using frequency matching and stratifying on age (group-
ings of 18e55, 56e65, 66e75, >75), sex, and year of THA (1995e
2005), from the approximately 124,000 people (2000 US census)ergoing
l hip
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udy and the number of patients with body weight data at each time point.
Table I
Characteristics of the THA and Rochester REP samples*
N(%) REP
(n ¼ 277)
THA
(n ¼ 597)
Chi-square
P-valuey
Male gender 119 (43) 252 (42) 0.83
Education 0.33
<H.S. 27 (11) 54 (9)
H.S. or some college 149 (61) 332 (57)
4 years college 69 (28) 192 (33)
Missing 32 19
Deyo-Charlson index 0.18
¼0 129 (47) 271 (45)
¼1 70 (25) 125 (21)
>1 78 (28) 201 (34)
Age 0.89
50 43 (16) 89 (15)
50e59 46 (17) 104 (17)
60e69 77 (28) 172 (29)
70e80 78 (28) 174 (29)
>80 33 (12) 58 (10)
Baseline BMI 0.053
<25 86 (31) 146 (25)
25e29.9 96 (35) 210 (35)
30e34.9 63 (23) 150 (25)
35e40 23 (8) 49 (8)
>40 7 (3) 39 (7)
Missing 2 3
1-year data present 207 (75) 393 (66) 0.008
2-year data present 201 (73) 401 (67) 0.11
3-year data present 197 (71) 372 (62) 0.01
4-year data present 187 (68) 371 (62) 0.12
5-year data present 178 (64) 348 (58) 0.09
BMI (calculated as the weight in kilograms divided by height in meters squared).
Estimates in bold are statistically signiﬁcant.
* Data are given as mean (SD) for continuous variables and percentage for cate-
gorical variables unless otherwise indicated.
y P-value for t-test was used for continuous variables and X2 for categorical
variables.
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surgery or were diagnosed with any form of cancer other than basal
cell carcinoma during the study period. For the REP data, body
weight collection rates ranged from 99.3% for the baseline surgery
index date to 64% for the 5-year post-operative index date. The
Mayo Clinic Institutional Review Board approved the study and all
subjects provided informed consent.
We recruited three trained chart abstractors who extracted data
from charts of all persons in both the THA cohort and the random
sample of REP community residents for a total of 874 chart reviews.
Abstractors reviewed charts for height, weight, education status
and Deyo-Charlson comorbidity scores34,35. Cancer diagnoses were
found through electronic medical record searches. International
Classiﬁcation of Diseases ninth edition diagnosis codes, or cancer
diagnostic labels in cases where abstractors found additional
cancer diagnoses were used to identify cancer diagnoses during the
study period (1995e2005).
The a priori power analysis was conducted to estimate the
number of persons required to detect a difference among THA and
REP groups. Assuming a common standard deviation (SD) for
weight change over 5 years of 4.5 kgs36,37 and using a two-sided,
two-sample t test to compare 5 year weight change, we needed
720 patients with THA and 270 community residents to provide
greater than 80% power to detect a body weight difference in group
means of 1 kg or more.
Assessment of body weight and BMI
During each medical visit, whether for THA follow-up or for any
type of medical visit, all persons in the Mayo Clinic health system
undergo routine height and weight measurements on digital scales
that are calibrated yearly by hospital and clinic staff. Trained chart
abstractors extracted yearly height and weight data on the index
date (day of surgery) and each year for 5 years prior to and 5 years
after the THA surgery date (in total, this covered years 1990e2010,
depending on the index surgery date). Abstractors were instructed
to extract yearly height and weight data that were as close to the
yearly anniversary dates of the index surgery date. Height and
weight data for the REP subjects were extracted by chart
abstractors for the 5 years prior to and 5 years following the
matched cases’ THA index dates. Overall, yearly body weight
collection rates from the chart reviews of the THA patients for
the 5 years following surgery ranged from 99.5% at baseline to
58.3% at 5 years.
Outcome variable of interest
We categorized THA and REP subjects as weight gainers if they
gained 5% of body weight from the index date to ﬁnal follow-
up. Persons who did not gain 5% or more of their body
weight were classiﬁed as weight maintainers. A 5% or greater
gain in body weight has been found to lead to clinically mean-
ingful effects on cardiovascular and diabetes related disorders as
well as pain and function28,29,38, and has been recommended as
a threshold for clinically meaningful weight loss in multiple
guidelines26,27.
Potential baseline predictor variables
We examined the following variables in the THA and REP
cohorts: (1) case control status categorized as either REP or THA. In
addition, persons with THA were further grouped into those with
and those without follow-up arthroplasty surgery of the contra-
lateral hip or either knee during 5 years of follow-up; (2) age,
categorized in approximate quartiles as follows, <60 years,60e69 years, 70e75 years and >75 years; (3) sex; (4) comorbidity,
assessed using the Deyo-Charlson index, a validated comorbidity
scale that includes 17 comorbidities with higher scores indicating
greater comorbidity; 34,35(5) baseline BMI (kg/m2) categorized into
<25, 25.0e29.9, 30e34.9, and 35 with <25 (mild thinness to
normal weight) being the referent group; 39(6) education, catego-
rized into three groups [<high school (HS) diploma, HS diploma or
some college, at least 4 years of college]; and (7) two additional
variables created to account for extent of weight gain or loss in the
5 years prior to surgery. For maximum 5-year pre-THAweight loss,
we subtracted the largest weight in the 5 years prior to surgery
from the index weight (e.g., day of surgery for the THA group and
matched date for the REP group). If the subject demonstrated no
weight loss in the 5 years prior to the index date, this variable was
coded as zero.We used a similar approach to indicate the amount of
weight gain that occurred from up to 5 years prior to the index
surgery date up to the date of surgery. We reasoned that if the
subject had either lost or gained weight in the years leading up to
the index date, the extent of weight gain following the index date
may be impacted by this pre-surgical weight variation40.
Statistical analyses
Descriptive statistics are reported in Table I for the characteris-
tics of the THA patients and the REP community residents. A t-test
or Chi-square test, as appropriate, was used to compare baseline
characteristics of patients with the population-based controls (see
Table I) and the combined THA and REP samples of those without
missing data at years 2 and 4 (see Table II).
We used two logistic regression models to analyze variables
associated with clinically important weight gain, accounting for
Table III
Percentage of subjects in the total hip and REP samples who gained a clinically
important amount of body weight
Post-
operative
year
THA sample REP sample
Number
assessed
% with clinically
important
weight gain
Number
assessed
% with clinically
important
weight gain
Year 1 393 121 (30.8%) 207 27 (13.0%)
Year 2 401 140 (34.9%) 201 36 (17.9%)
Year 3 372 126 (33.9%) 197 44 (22.3%)
Year 4 371 142 (38.3%) 187 51 (27.3%)
Year 5 348 132 (37.9%) 178 50 (28.1%)
Table II
Relationship between non-missing 2- and 4-year weight data and baseline char-
acteristics for the combined samples*
N(%) Two-year data Four-year data
Present P-valuey Present P-valuey
Gender 0.006 0.07
Female 365 (73) 334 (66)
Male 237 (64) 224 (60)
Education 0.18 0.50
<H.S. 56 (69) 51 (63)
H.S. or some college 348 (72) 324 (67)
4 years college 172 (66) 166 (64)
Charlson index 0.18 0.53
¼0 263 (66) 253 (63)
¼1 139 (71) 131 (67)
>1 200 (72) 174 (62)
Age <0.001 0.005
50 71 (54) 71 (54)
50e59 101 (67) 98 (65)
60e69 176 (71) 167 (67)
70e80 187 (74) 174 (69)
>80 67 (74) 48 (53)
Baseline BMI 0.47 0.67
<25 157 (68) 146 (63)
25e29.9 204 (67) 194 (63)
30e34.9 152 (71) 135 (63)
35e40 55 (76) 52 (72)
>40 33 (72) 30 (65)
BMI (calculated as the weight in kilograms divided by height in meters squared).
Estimates in bold are statistically signiﬁcant.
* Data are given as mean (SD) for continuous variables and percentage for cate-
gorical variables unless otherwise indicated.
y P-value for t-testwas used for continuous variables andX2 for categorical variables.
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statement). The ﬁrst model compared the THA sample to the REP
sample. The second model examined only the THA sample. The
primary purpose of this second model was to identify pre-surgical
risk factors for clinically important weight gain in the 5 years
following surgery.
The second logistic regression model of only the THA group also
included as predictor variables, diagnosis [osteoarthritis (OA) vs
rheumatoid arthritis (RA)] and American Society of Anesthesiolo-
gists (ASA) score, a validated measure of immediate post-operative
morbidity and perioperative mortality and scored as classes `IeII vs
IIIeIV41,42. The American Society of Anesthesiology41,42 score was
retrieved using a registry maintained by the department of Anes-
thesiology. Statistical analyses were performed with SAS statistical
software, version 9.2 (SAS Institute, Cary, North Carolina, USA).
Two-way interactions were assessed in both models.
Because of the imbalance in baseline BMI distributions between
the THA and REP groups, we conducted a sensitivity analysis using
the Marginal Structural Models method as described by Robbins
and colleagues43. For the THA patients, case weights were used to
balance the distribution of baseline BMI between the THA and REP
patients to allow for statistical comparisons of THA and REP groups
when baseline BMI distributions were equivalent.
Results
The THA sample (n ¼ 597 persons with 96 undergoing addi-
tional knee or contralateral hip arthroplasty procedures during the
5-year follow-up) and the population-based control sample
descriptions and comparisons appear in Table I. Baseline attributes
were not signiﬁcantly different between groups. With the excep-
tion of a preferential loss to follow-up of males at year 2 and
persons younger than 50 years or older than 80 years at years 2 and
5, samples with and without missing data at years 2 and 4 were
similar for the baseline attributes (see Table II).A total of 92% of our THA sample and 100% of the REP sample
had at least one follow-upweight measure in the analyses. Over the
5-year post-operative period, the control group (n ¼ 275) gained
a mean of 0.02 kg (SD ¼ 4.7). The patients with subsequent addi-
tional knee or hip arthroplasty(ies) (n ¼ 96) during the 5-year
follow-up gained a mean of 3.35 kg (SD ¼ 5.6) while cases with
no additional lower extremity arthroplasty during 5 years of
follow-up (n ¼ 501) gained a mean of 2.12 kgs (SD ¼ 6.2). The
percentage of persons in the THA and REP groups who gained
a clinically important amount of body weight varied each year
during the 5-year post-operative period (see Table III). For example,
at the 1-year post-operative time point, 13.0% (27/207) of the REP
sample gained 5% of their baseline body weight while 30.8%
(121/393) of the THA sample gained 5% of baseline body weight.
In univariate analyses, patients undergoing a single THA had an
odds of gaining 5% body weight up to 5 years following surgery
that was more than double that of the control group [OR ¼ 2.1, 95%
conﬁdence interval (CI), 1.6, 2.8]. Patients undergoing at least one
additional arthroplasty during the follow-up period had a signiﬁ-
cantly higher odds [odds ratio (OR ¼ 2.3, 95% CI, 1.5, 3.3)] of clini-
cally important weight gain relative to the REP sample. In the
multi-variable model, the odds for a 5% body weight gain in the
THA group with no follow-up arthroplasty was 1.7 (95% CI, 1.1, 2.6),
after adjusting for potential confounders (see Table IV). Patients
with multiple arthroplasty had double the odds OR ¼ 2.0 (95% CI,
1.4, 2.7) of clinically important weight gain relative to the REP
sample. Our sensitivity analysis (see Table VI) whichweighted cases
to balance the distributions of BMI categories among the REP and
THA groups found very similar estimates to those reported in
Table IV.
For the multi-variable logistic regression model examining only
patients in the THA sample, thosewhoweremost likely to gain5%
body weight lost more weight in the 5 years prior to surgery. The
odds for a clinically important post-surgical weight gain increased
by 12% [OR ¼ 1.12, (95% CI, 1.08, 1.16)] for every kilogram of body
weight lost during the 5 year pre-operative period. Persons with
a baseline BMI of between 30 and 34.9 kg/m2 had a 40% reduced
risk of clinically important weight gain (OR ¼ 0.6, 95% CI, 0.4, 0.96)
relative to the referent group (BMI < 25 kg/m2). In addition,
persons aged 70e75 years had a 60% reduced risk of clinically
important weight gain (OR ¼ 0.4, 95% CI, 0.2, 0.7) relative to the
referent group of persons aged >75 years (see Table IV). Follow-
up arthroplasty procedures did not increase risk of post-surgical
weight gain in the THA sample. No two-way interactions were
found for any of the models.Discussion
We found that persons undergoing THAwere at increased risk of
clinically important weight gain relative to a population-based
sample of persons from the same geographic region who did not
Table IV
Logistic regression model of clinically important weight gain (5% body weight) in persons with THA and persons from the REP
Variable Unadjusted analysis Adjusted analysis
OR (95% CI) P-value Overall P-valuez OR (95% CI) P-value Overall P-value
Subject status <0.001 <0.001
THA (follow-up arthroplasty) 2.3 (1.5, 3.3) <0.001 2.0 (1.4, 2.7) <0.001
THA (no follow-up arthroplasty) 2.1 (1.6, 2.8) <0.001 1.7 (1.06, 2.6) 0.03
REP group 1.0 (ref) 1.0 (ref)
BMI 0.02 0.003
25.0e29.9 0.8 (0.6, 1.02) 0.06 0.7 (0.5, 0.99) 0.05
30.0e34.9 0.6 (0.4, 0.8) 0.002 0.5 (0.3, 0.7) <0.001
35 0.9 (0.6, 1.3) 0.4 0.7 (0.4, 1.03) 0.07
<25 1.0 (ref) 1.0 (ref)
Age <0.001 <0.001
<60 1.5 (1.1, 2.1) 0.01 2.0 (1.3, 3.0) 0.001
60e69 1.0 (0.7, 1.3) 0.76 1.1 (0.7, 1.6) 0.68
70e75 0.5 (0.4, 0.8) 0.004 0.6 (0.4, 0.96) 0.03
>75 1.0 (ref) 1.0 (ref)
Gender
Male 1.0 (0.8, 1.3) 0.88 0.9 (0.7, 1.2) 0.46
Female 1.0 (ref) 1.0 (ref)
Education 0.15 0.65
<HS diploma 0.8 (0.5, 1.2) 0.24 0.9 (0.5, 1.6) 0.76
HS or some college 0.8 (0.6, 1.01) 0.06 0.9 (0.7, 1.2) 0.35
College degree or > 1.0 (ref) 1.0 (ref)
Deyo-Charlson index 0.07 0.03
0 1.1 (0.9, 1.5) 0.40 1.2 (0.9, 1.7) 0.20
1 0.8 (0.6, 1.1) 0.16 0.8 (0.5, 1.1) 0.20
>1 1.0 (ref) 1.0 (ref)
Pre-surgical 5-year max wt loss, per 1 kg* 1.12 (1.1, 0.15) <0.001 1.13 (1.1, 1.2) <0.001
Pre-surgical 5-year max wt gain, per 1 kgy 1.0 (0.96, 1.03) 0.74 1.0 (0.97, 1.04) 0.79
BMI (calculated as the weight in kilograms divided by height in meters squared). Estimates in bold are statistically signiﬁcant.
* Maximum weight loss (in kgs), relative to baseline, during the 5 years prior to the baseline knee arthroplasty.
y Maximum weight gain (in kgs), relative to baseline, during the 5 years prior to the baseline knee arthroplasty.
z The overall P-value describes the extent of statistical signiﬁcance among the levels for each variable with more than two levels.
Table V
Logistic regression model of clinically important weight gain (5% body weight) among persons with THA
Variable Unadjusted analysis Adjusted analysis
OR (95% CI) P-value Overall P-valuez OR (95% CI) P-value Overall P-value
Subject status
THA (follow-up arthroplasty) 1.1 (0.8, 1.5) 0.66 0.9 (0.6, 1.3) 0.58
THA (no follow-up arthroplasty) 1.0 (ref) 1.0 (ref)
BMI 0.12 0.25
25.0e29.9 0.8 (0.6, 1.2) 0.29 0.8 (0.5, 1.2) 0.23
30.0e34.9 0.7 (0.5, 0.9) 0.02 0.6 (0.4, 0.98) 0.04
35 0.9 (0.6, 1.5) 0.80 0.7 (0.4, 1.3) 0.28
<25 1.0 (ref) 1.0 (ref)
Age <0.001 <0.001
<60 1.5 (1.01, 2.2) 0.05 1.6 (0.96, 2.6) 0.07
60e69 1.1 (0.8, 1.6) 0.61 1.1 (0.7, 1.7) 0.73
70e75 0.5 (0.3, 0.8) 0.005 0.4 (0.2, 0.7) <0.001
>75 1.0 (ref) 1.0 (ref)
Gender
Male 1.0 (0.7, 1.3) 0.91 0.8 (0.6, 1.1) 0.19
Female 1.0 (ref) 1.0 (ref)
Diagnosis
OA 1.1 (0.7, 1.8) 0.64 1.3 (0.8, 2.3) 0.27
Other 1.0 (ref) 1.0 (ref)
Education 0.09 0.42
<HS diploma 0.6 (0.3, 1.1) 0.10 0.8 (0.4, 1.5) 0.46
HS or some college 0.8 (0.6, 1.01) 0.06 0.8 (0.6, 1.1) 0.20
College degree or > 1.0 (ref) 1.0 (ref)
ASA score
III or IV 0.9 (0.6, 1.2) 0.34 0.8 (0.6, 1.2) 0.33
I or II 1.0 (ref) 1.0 (ref)
Charlson index 0.14 0.21
0 1.4 (0.97, 1.9) 0.07 1.3 (0.9, 1.9) 0.22
1 1.0 (0.7, 1.5) 0.96 0.9 (0.6, 1.3) 0.48
>1 1.0 (ref) 1.0 (ref)
Pre-surgical 5-year max wt loss, per 1 kg* 1.11 (1.07, 1.14) <0.001 1.12 (1.08, 1.16) <0.001
Pre-surgical 5-year max wt gain, per 1 kgy 1.0 (0.96, 1.04) 0.99 1.0 (0.96, 1.05) 0.90
Estimates in bold are statistically signiﬁcant.
* Maximum weight loss (in kgs), relative to baseline, during the 5 years prior to the baseline knee arthroplasty.
y Maximum weight gain (in kgs), relative to baseline, during the 5 years prior to the baseline knee arthroplasty.
z The overall P-value describes the extent of statistical signiﬁcance among the levels for each variable with more than two levels.
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Table VI
Sensitivity analysis correcting for imbalances in baseline BMI distributions among THA and REP cohorts
Variable Unadjusted analysis Adjusted analysis
OR (95% CI) P-value Overall P-valuez OR (95% CI) P-value Overall P-value
Subject status <0.001 <0.001
THA (follow-up arthroplasty) 2.6 (1.8, 4.0) <0.001 1.8 (1.2, 2.8) 0.009
THA (no follow-up arthroplasty) 2.2 (1.6, 2.9) <0.001 2.0 (1.5, 2.8) <0.001
REP group 1.0 (ref) 1.0 (ref)
BMI 0.02 0.003
25.0e29.9 0.8 (0.6, 1.04) 0.08 0.7 (0.5, 0.99) 0.04
30.0e34.9 0.6 (0.4, 0.9) 0.005 0.5 (0.3, 0.7) <0.001
35 1.2 (0.8, 1.8) 0.48 0.8 (0.5, 1.3) 0.34
<25 1.0 (ref) 1.0 (ref)
Age <0.001 <0.001
<60 1.7 (1.2, 2.4) 0.004 1.9 (1.2, 2.9) 0.003
60e69 1.0 (0.7, 1.5) 0.98 1.1 (0.7, 1.6) 0.74
70e75 0.5 (0.3, 0.8) 0.007 0.6 (0.3, 0.95) 0.03
>75 1.0 (ref) 1.0 (ref)
Gender 0.65
Male 1.0 (0.7, 1.3) 0.88 0.9 (0.6, 1.2) 0.33
Female 1.0 (ref) 1.0 (ref)
Education 0.15 0.03
<HS diploma 0.7 (0.4, 1.2) 0.17 0.9 (0.5, 1.5) 0.59
HS or some college 0.8 (0.6, 1.04) 0.09 0.8 (0.6, 1.1) 0.19
College degree or > 1.0 (ref) 1.0 (ref)
Deyo-Charlson index 0.07
0 1.3 (0.9, 1.8) 0.13 1.4 (0.99, 2.1) 0.06
1 0.8 (0.6, 1.2) 0.35 0.9 (0.6, 1.3) 0.55
>1 1.0 (ref) 1.0 (ref)
Pre-surgical 5-year max wt loss, per 1 kg* 1.13 (1.10, 1.16) <0.001 1.14 (1.11, 1.18) <0.001
Pre-surgical 5-year max wt gain, per 1 kgy 1.02 (0.98, 1.05) 0.37 1.01 (0.98, 1.05 0.44
BMI (calculated as the weight in kilograms divided by height in meters squared). Estimates in bold are statistically signiﬁcant.
* Maximum weight loss (in kgs), relative to baseline, during the 5 years prior to the baseline knee arthroplasty.
y Maximum weight gain (in kgs), relative to baseline, during the 5 years prior to the baseline knee arthroplasty.
z The overall P-value describes the extent of statistical signiﬁcance among the levels for each variable with more than two levels.
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bodyweight over the 5-year post-operative period for persons with
THA was 70% higher than the population-based REP sample. Odds
of clinically important weight gain doubled, on average, relative to
that of the REP sample for persons who underwent at least one
additional arthroplasty procedure during the 5-year post-operative
period. Persons with a higher BMI and persons aged 70e75 years
were less likely to gain weight as compared to other BMI and age
categories. Older persons are known to be less likely to gain
weight than younger adults9e11 and this was consistent with our
ﬁndings. Persons with the lowest BMI (<25 kg/m2) were most at
risk for clinically important weight gain and this may be attribut-
able to the fact that they needed to gain the least amount of weight
to reach the 5% threshold.
In the multi-variable analysis, patients with THA (Table V) were
at risk for clinically important weight gain at the rate of 12% for
every kg of weight lost during the 5 years prior to surgery. Some
THA patients were protected from risk of important weight gain
and these were patients in the BMI range of 30e34.9 kg/m2
compared to those with a BMI of <25 kg/m2, and those aged 70e
75 years, relative to patients aged >75 years. Overweight or
obese patients with THA who had higher or lower BMIs than the
30e34.9 range were not protected from subsequent weight gain
relative to THA patients with body weight in the normal range of
<25 kg/m2. Even with a reduced risk for post-surgical weight gain
for patients in the 30 to <35 kg/m2 BMI category, we still support
weight loss counseling given these patients’ risks for obesity
related disorders and excessive joint loading. Persons with THA
aged <60 years were 60% more likely (OR ¼ 1.6, 95% CI ¼ 0.96, 2.6)
to experience important weight gain relative to patients aged
>75 years.
These ﬁndings, in total, suggest that patients undergoing
primary THA are at risk for weight gain, relative to population-based peers, even after adjusting for age, gender and baseline
BMI. These data suggest that all THA patients who are overweight
or obese should be counseled about weight loss and the higher than
normal risk of important post-surgical weight gain. Our data
suggest risk for weight gain doesn’t vary substantially from the ﬁrst
to the ﬁfth year post surgery (see Table III). Patients should bemade
aware that weight gain risk begins within the ﬁrst year and persist
for at least 5 years following surgery. Compared to their peers,
persons with multiple arthroplasties are at even higher risk of
clinically important weight gain.
Work by Paans and colleagues12 suggests that persons with
BMIs higher than 25 kg/m2 tend to lose weight after surgery and
persons in the highest BMI category (>30 kg/m2) lose the most
weight, 6.2 kgs, on average, at 4.5 years follow-up. Our ﬁndings are
not consistent with this evidence. We speculate that these differ-
ences may be attributable either to differences in reporting (i.e.,
Paans and colleagues did not report the proportion of patients
gaining5% of body weight and relied on self-reported weight and
height) or to social and cultural differences across the two coun-
tries. In the US, adult obesity rates (BMI30) are 36%44 while in the
Netherlands, approximately 12% of Dutch adults are obese45. In
addition, in the Netherlands walking and bicycling are preferred
modes of transportation for adults in contrast to the US12. These
data suggest that activity levels are generally higher in Dutch
populations and this increased mobility may be contributing to the
differential effects of THA on post-surgical weight gain for over-
weight and obese patients in the US and in the Netherlands.
Dowsey and colleagues studied 474 THA Australian patients and
found that 25% had gained5% of baseline body weight in 1-year16.
We had similar ﬁndings in our study with 30.8% of THA patients
gaining 5% of their baseline weight 1-year after surgery. Others
also found weight gain more than 1 year post-operatively. Mid-
dleton and colleagues reported a signiﬁcant BMI mean increase of
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a sample of 180 overweight or obese patients from England19.
Aderinto and colleagues reported a mean gain of 2.3 kgs in 140
Scottish patients 3 years following THA with obese patients
(BMI  30) showing the greatest weight gains20.
Of particular importance is the role of pre-operative weight loss
as a risk factor for post-operative weight gain. Patients with THA
who lose weight are likely to gain back at least some of this weight
after surgery. Future research should examine interventions
designed to maintain weight loss in this sub-group at risk for post-
operative weight gain. Weight gain following surgery is particularly
important for women who are at increased risk of future hip
arthroplasty due to weight gain46.
The only other study that identiﬁed pre-operative risk factors
for important post-operative weight gain was the work of Dowsey
and colleagues16. The only pre-operative predictor of a 5% body
weight gain was a lower SF-12 mental health score. Forman-
Hoffman examined whether baseline depressive symptoms
increased risk for weight gain of 5% body weight over an 8-year
period in a sample of 9,130 women and men aged 53e63 years47.
Baseline depressive symptoms were found to predict subsequent
important weight gain in women but not in men. More research
needs to examine the potential role of mental health generally and
speciﬁc mental health disorders such as depression in patients
undergoing THA.
Our study found that pre-operative weight loss prior to THA
surgery and age less than 60 years are independent risk factors for
post-surgical weight gain. Intentional weight loss is known to
frequently lead to subsequent weight gain48,49. Overweight and
obese patients preparing for THA are frequently advised by their
surgeons to lose weight but, in our experience, patients receive
little formal instruction on weight loss maintenance. Evidence
suggests pre-operativeweight loss will reduce risk of complications
and potentially revision surgery50 and while pre-surgical weight
loss may aid in enhancing early recovery, our data suggests at least
a portion of the weight is gained back after surgery. Weight ﬂuc-
tuation increases risk of a variety of disorders51,52 which argues for
future research designed to identify effective weight control strat-
egies to minimize ﬂuctuations.
Our study has some notable limitations. Loss to follow-up was
substantial with over 40% of THA patients and over 30% of control
subjects with missing weight data at 5 years. We found only subtle
differences among those with complete and those with missing
follow-up weight data (see Table II), but these differences along
with unmeasured confounding may have inﬂuenced our ﬁndings.
We do not know whether the weight changes in our subjects were
intentional or unintentional and we do not know what would have
happened to our THA patients’ weight had they not had surgery.
Reasons for weight change may inﬂuence outcome following THA
surgery52. There appears to be differential effects of THA depending
on the country or region of the world being studied. Our results
may not generalize to some countries.
Given our limitations and particularly our missing follow-up
body weight data, our study suggests an association between THA
surgery and subsequent clinically important weight gain relative to
that seen in a population-based control sample. Compared to an
age and gender matched population and after adjusting for
potential confounders including baseline BMI differences, patients
undergoing THA, and particularly patients undergoing multiple
arthroplasty surgeries are at risk of clinically important weight gain
up to 5 years following THA surgery. The most powerful indepen-
dent risk factor for post-operative weight gain speciﬁcally among
patients with THA appears to be pre-operative weight loss and age
less than 60 years. For every kilogram of 5-year pre-operative
weight loss, risk for clinically important weight gain increases by12%. Patients who have lost more substantial amounts of weight in
the years leading up to surgery are particularly vulnerable to post-
surgical weight gain.
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